• 简体中文
    • English
    • 日本語
LE Simplified Chinese logoLE Simplified Chinese logo 601LE Simplified Chinese logoLE Simplified Chinese logo
  • 服务
    • 专利
    • 商标
    • 版权
    • 诉讼
  • 专家
  • 真知灼见
  • 关于
    • Careers and Diversity
    • Pro Bono
  • 联系我们
  • 服务
    • 专利
    • 商标
    • 版权
    • 诉讼
  • 专家
  • 真知灼见
  • 关于
    • Careers and Diversity
    • Pro Bono
  • 联系我们
Melvin Garner And Lauren Emerson Present At AIPLA Annual Meeting
2020 年 10 月 27 日
Dr. Susie Cheng Submitted Comments To Draft Measures On China Patent Linkage And Wrote For Medicine Economic News
2020 年 11 月 06 日

Generic Drugs

2020 年 10 月 29 日
China’s NMPA and CNIPA Propose Draft Measures banner

The China National Medical Products Administration (“NMPA”-China FDA) and China National IP Administration (“CNIPA”) have recently solicited public comments on the proposed rules on patent linkage system (similar to the US orange book) aiming to implement early resolution mechanisms for drug patent disputes. The proposed rules draw from the U.S. Hatch-Waxman framework for resolving patent disputes. From the direction of the current proposed rules, there are substantial implications on pharmaceutical and biotech companies doing business in China. While the Draft Measures are good news overall for innovative drug applicants, patentees and the generic drug industry in China, Innovators and pharmaceutical companies that are interested in the China drug market should evaluate their business objectives and take this opportunity to discuss with their legal counsel regarding the proposed legislation. On behalf of our pharmaceutical and biotechnology clients, we have submitted comments and proposed amendment of the law to the NMPA in response to the solicitation.

Read more
Share

类别

  • 文章
    • 专利法
    • 商标法
    • 版权法
    • 广告法
  • 判决
    • 专利法
    • 商标法
    • 版权法
  • Leason Ellis 新闻
  • Leason Ellis 新闻通讯
  • 未分类
  • Leason Ellis 视频
Print Friendly, PDF & Email
One Barker Avenue
White Plains, New York 10601
电话 914.288.0022
  • 服务
    • 专利
    • 商标
    • 版权
    • 诉讼
  • 专家
  • 真知灼见
  • 关于
    • Careers and Diversity
    • Pro Bono
  • 联系我们
Facebook LinkedIn Twitter
  • 订阅我们的新闻
© 2022 Leason Ellis | 客户门户 | 隐私声明 |免责声明 | 条款及细则 | 律师广告
    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept,” you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT